APO-APREMILAST

Identification of Apo-Apremilast

No description

Google image searchProduct monograph

Active ingredient

apremilast, 30 MG

DIN: 02538180

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: APOTEX INC

Date: 28-SEP-2023

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AA — Selective immunosuppressants (ATC, ATC/DDD)
• L04AA32 — APREMILAST (ATC/DDD)

External Links for Apo-Apremilast

Search on Google

• Apo-Apremilast side effects
• Apo-Apremilast dosage
• apremilast side effects
• apremilast dosage

Apotex Inc

Go to Apotex website to see drug product details. Sometimes you can find apo-apremilast photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.